{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 0,
        "end": 4
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 59,
        "end": 68
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 44,
        "end": 48
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 122,
        "end": 126
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 122,
        "end": 161
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 44,
        "end": 58
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 72,
        "end": 75
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 135,
        "end": 138
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27025877_4",
  "text": "JAK2 inhibition restored sensitivity to the EGFR inhibitor erlotinib in TKI -resistant cell lines and xenograft models of EGFR -mutant TKI -resistant lung cancer ."
}
